Last reviewed · How we verify
NCT04182152
Bronchoscopic ICG Injection and Percutaneous Hook-wire Techniques for Preoperative Lung Nodule Localization in VATS
NA trial testing Indocyanine green (ICG) in Lung Cancer in 188 participants. Status unknown.
5 November 2020
Quick facts
| Lead sponsor | Jiayuan Sun |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 188 |
| Start date | 5 November 2019 |
| Primary completion | 5 November 2020 |
| Estimated completion | 5 December 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Indocyanine green (ICG) — full drug profile →
- Electromagnetic navigation bronchoscopy
- Hook wire
Conditions studied
- Lung Cancer — all drugs for Lung Cancer →
Sponsor
Jiayuan Sun
Who can join
18 and older, any sex, with Lung Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to evaluate the efficacy and safety of transbronchial ICG and percutaneous hook-wire assisted Video-assisted thoracoscopic sublobar resection. In the control group, CT-guided percutaneous hook-wire preoperative localization will be used for surgical resection; In the experimental group, electromagnetic navigation bronchoscopy guided transbronchial ICG injection will be performed for localization before VATS.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
How effective is indocyanine green (ICG) in localization of malignant pulmonary nodules? A systematic review and meta-analysis.
Gkikas A, Lampridis S, Patrini D, Kestenholz PB, et al · · 2022 · cited 13× · PMID 35959126 · DOI 10.3389/fsurg.2022.967897
Verify or expand the search:
- PubMed search for NCT04182152
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Indocyanine green (ICG)
Trials testing the same drug.
- NCT06979115 — Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bo · not yet recruiting
Other recruiting trials for Lung Cancer
Currently open trials in the same condition.
- NCT07295821 — Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study · Phase 2 · recruiting
- NCT06909201 — Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigatin · Phase 1 · recruiting
- NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
- NCT07487064 — Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study · NA · recruiting
- NCT07146568 — Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hos · NA · recruiting
Other Jiayuan Sun trials
Trials by the same sponsor.
- NCT07277088 — The Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy · NA · not yet recruiting
- NCT06572540 — Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer · NA · recruiting
- NCT05771129 — Feasibility Study of the Pulsed Electric Field Ablation System in Treating Chronic Bronchitis · NA · unknown
- NCT03903471 — 22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA · NA · unknown
- NCT04413669 — Bronchoscopy Screening for High-risk Population of Lung Cancer With Severe Smoking With Negative LDCT Screen · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04182152 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jiayuan Sun
- Last refreshed: 2 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04182152.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing